The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYR.L Regulatory News (HYR)

  • There is currently no data for HYR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Trading Update

26 Oct 2017 07:00

RNS Number : 6492U
HydroDec Group plc
26 October 2017
 

26 October 2017

 

Hydrodec Group plc

("Hydrodec", the "Company" or the "Group")

 

Q3 Trading Update

 

Hydrodec Group plc (AIM: HYR), the cleantech industrial oil re-refining group, is pleased to provide a trading update for the quarter ended 30 September 2017.

 

Highlights

· Strongest quarterly EBITDA performance in Group's history, with Group EBITDA expected to exceed US$330,000, representing an improvement of US$605,000 on the comparable period last year (Q3 2016: loss of US$275,000), driven by improved pricing and margins and reductions in corporate costs

· Revenues expected to exceed US$4.7 million (Q3 2016: US$4.3 million)

· Group sales volumes of premium quality SUPERFINE transformer oil and base oil of 7.7 million litres (Q3 2016: 8.2 million litres)

· Canton plant utilisation consistent with H1 2017 at 61% - feedstock remains key constraint to higher throughput and strategic initiatives continue to progress in securing sustainable, increased supplies going forward

· Gross unit margins materially up on prior year at 14% (Q3 2016: 7%) - driven by improved sales mix in the US between higher margin transformer oil and lower margin base oil - and further improvement on H1 (H1 2017: 13%)

· In the US business, the Company is pleased to confirm the award of a two year agreement to supply up to 7.6 million litres annually of its SUPERFINE transformer oil to a major transformer original equipment manufacturer ("OEM")

Outlook

This update confirms the progress over the past 12 months, with Q3 demonstrating further improvement over the recent half year results. Demand for our product remains robust and the award of a two year contract from a major OEM in the US underlines the quality of the product the Company produces. The focus remains on expanding the number and value of significant feedstock contracts that in turn will drive the utilisation of the operations and further improve the Group's EBITDA and cash-flow generation going forward.

 

Chris Ellis, Chief Executive Officer of Hydrodec, commented: "I am very pleased to confirm further strong progress in positive Group EBITDA in the most recent quarter of 2017, as much of the recent hard work begins to reap its reward. As indicated at the beginning of the year, I am confident that 2017 will see the Group deliver full year positive EBITDA for the first time in its history, with scope for further material improvement from the existing facilities. While maintaining a sharp focus on the operational performance of the business, we will look for opportunities to deploy our clean-tech re-refining technology to capitalise on the large market opportunity that we see."

 

For further information, please contact:

 

Hydrodec Group plc

 

01372 824750

Chris Ellis, Chief Executive

 

 

 

Canaccord Genuity (Nominated Adviser and Broker)

 

020 7523 8000

Henry Fitzgerald-O'Connor

Richard Andrews

 

 

 

Vigo Communications (PR adviser to Hydrodec)

 

020 7830 9700

Patrick d'Ancona

Chris McMahon

 

 

Notes to Editors:

Hydrodec's technology is a proven, highly efficient, oil re-refining and chemical process initially targeted at the multi-billion US$ market for transformer oil used by the world's electricity industry. MarketsandMarkets forecasts that the global transformer oil market is expected to grow from US$1.98 billion in 2015 to US$2.79 billion by 2020 at a CAGR of 7.14% from 2015 to 2020. Spent oil is currently processed at two commercial plants with distinct competitive advantage delivered through very high recoveries (near 100%), producing 'as new' high quality oils at competitive cost and without environmentally harmful emissions. The process also completely eliminates PCBs, a toxic additive banned under international regulations.

 

In 2016 Hydrodec received carbon credit approval from the American Carbon Registry ("ACR"), enabling its product to be sold with a carbon offset and creating an incremental revenue stream. The Group is now generating carbon offsets through the re-refining of used transformer oil, which would otherwise ordinarily be incinerated or disposed of in an unsustainable manner. This is a highly distinctive feature for the Group, confirming (as far as the Board is aware) Hydrodec as the only oil re-refining business in the world to receive carbon credits for its output. This is a significant endorsement of the Company's proprietary technology and standing as a leader in its field.

 

Hydrodec's plants are located at Canton, Ohio, US and Bomen, New South Wales, Australia. 

 

Hydrodec's shares are listed on the AIM Market of the London Stock Exchange. For further information, please visit www.hydrodec.com.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLELLLDBFEFBF
Date   Source Headline
2nd Nov 20127:00 amRNSConvertible Unsecured Loan Stock
31st Oct 20123:37 pmRNSDirector's dealing in securities
31st Oct 20127:00 amRNSDirector's dealing in securities
25th Oct 20127:00 amRNSDirector's dealing in securities
24th Oct 20127:00 amRNSAppointment of Chairman
12th Sep 201210:50 amRNSNotification of Interest
6th Sep 20127:00 amRNSInterim Results
16th Aug 201211:13 amRNSNotification of Interim Results
9th Aug 20122:07 pmRNSDirectorate Change
6th Aug 201210:35 amRNSJoint marketing agreement
3rd Jul 20127:00 amRNSDirector's dealing
27th Jun 20122:37 pmRNSUS approves treatment of PCB-contaminated oil
25th Jun 201212:00 pmRNSResult of AGM
25th Jun 20127:00 amRNSAGM Statement
15th Jun 20127:00 amRNSContract Win
8th Jun 20121:03 pmRNSAppointment of Chief Financial Officer
22nd May 20124:17 pmRNSNotification of interest
4th May 201212:36 pmRNSDirector's Dealing
25th Apr 20124:15 pmRNSEPA issues draft approval
19th Apr 20127:00 amRNSFinal Results
3rd Apr 20127:00 amRNSNotice of Results
13th Mar 201211:53 amRNSChange of Registered Office
17th Feb 20123:44 pmRNSDirector Dealing
1st Feb 20122:25 pmRNSDirector's Dealing
30th Jan 20121:12 pmRNSDirectorate Change
25th Jan 20129:14 amRNSDirector's dealing
18th Jan 20125:35 pmRNSDirector's Dealing
17th Jan 20123:24 pmRNSDirector's dealing
16th Jan 20127:00 amRNSTrading Update
7th Dec 20117:00 amRNSAppointments
28th Nov 20113:30 pmRNSNotification of Interest
28th Nov 201112:15 pmRNSNotification of Interest
28th Nov 201111:43 amRNSTotal Voting Rights
21st Nov 201110:46 amRNSResult of General Meeting
3rd Nov 20113:15 pmRNSPosting of Circular
2nd Nov 20117:00 amRNSAppointment of CEO and Placing
31st Oct 20114:17 pmRNSRe press speculation
26th Sep 201111:26 amRNSDirector's dealing - Replacement
26th Sep 20117:00 amRNSDirector's dealing
21st Sep 20117:00 amRNSInterim Results
26th Aug 20113:00 pmRNSDirector change in information
12th Jul 20117:00 amRNSDirector's dealing
11th Jul 201111:28 amRNSSigning of first operating joint venture in Japan
23rd Jun 20117:00 amRNSDirectorate Change
9th Jun 201111:51 amRNSResult of AGM
9th Jun 20117:00 amRNSAGM Statement
8th Jun 20118:38 amRNSNotification of Interest
25th May 201110:01 amRNS£2 million debt financing to fund growth
17th May 201112:33 pmRNSAnnual Report & Notice of AGM
26th Apr 20115:17 pmRNSNotification of Interest

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.